<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04007887</url>
  </required_header>
  <id_info>
    <org_study_id>CARD EBD2369/12-05-2017</org_study_id>
    <nct_id>NCT04007887</nct_id>
  </id_info>
  <brief_title>Effect of an Adult EDUcation Program on CArdiovascular ouTcomEs in Post-myocardial-infarction Patients</brief_title>
  <acronym>EDUCATE</acronym>
  <official_title>Effect of an Adult Education Program on Cardiovascular Outcomes in Post-myocardial-infarction Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National and Kapodistrian University of Athens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National and Kapodistrian University of Athens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A non-MD-led adult education program consisting in 10 one-hour sessions designed to provide
      information and motivation will be offered to patients who have recently been hospitalized
      for acute myocardial infarction (STEMI and NSTEMI), regarding the management of their
      treatment and strategies to aggressively optimize control of cardiovascular risk factors..

      The intervention arm will be compared to a control group of patients treated with usual care.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to death or myocardial infarction or cerebrovascular event or unplanned hospitalization for cardiovascular reasons</measure>
    <time_frame>24 months</time_frame>
    <description>Time from randomization to the composite endpoint of death or myocardial infarction or cerebrovascular event or unplanned hospitalization for cardiovascular reasons</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACCE</measure>
    <time_frame>24 months</time_frame>
    <description>Major cardio-/cerebro-vascular events (cardiovascular death, myocardial infarction, cerebrovascular event)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in LDL-chol</measure>
    <time_frame>12 months</time_frame>
    <description>Change from baseline to 12 months in LDL-cholesterol concentration</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in body-mass index</measure>
    <time_frame>12 months</time_frame>
    <description>Change from baseline to 12 months in the body-mass index</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in arterial pressure</measure>
    <time_frame>12 months</time_frame>
    <description>Change from baseline to 12 months in systolic arterial pressure (the mean of 3 office measurements)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Post-MI patients attending an adult education program designed to inform and motivate them on how to best control cardiovascular risk factors as a means to offer optimized secondary prevention of cardiovascular events</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care for post-MI patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Adult education program</intervention_name>
    <description>A 10-hour program embodying major adult education principles, designed to achieve cognitive involvement of patients in their treatment</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History of acute ST-elevation myocardial infarction (STEMI) or non-ST-elevation
             myocardial infarction (NSTEMI), Type Ι, according to the 3rd Universal Definition of
             MI, within the preceding 6 weeks

          -  Absence of substantial cognitive dysfunction (Mini Mental State examination score ≥24)

        Exclusion Criteria:

        - Age &gt;80 years or &lt;18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Spyridon Deftereos, MD</last_name>
    <phone>00302105832352</phone>
    <email>spdeftereos@med.uoa.gr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Athens University Hospital Attikon</name>
      <address>
        <city>Athens</city>
        <zip>12462</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Spyridon Deftereos</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 30, 2019</study_first_submitted>
  <study_first_submitted_qc>July 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>July 27, 2019</last_update_submitted>
  <last_update_submitted_qc>July 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National and Kapodistrian University of Athens</investigator_affiliation>
    <investigator_full_name>Spyridon Deftereos</investigator_full_name>
    <investigator_title>Associate Professor of Cardiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

